Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,263.20
(
0.54%
)
Dow Jones
46,993.26
(
0.00%
)
Brent Oil
101.48
(
0.82%
)
Bitcoin
73,062.94
(
-1.19%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: ghmm post# 110938

Wednesday, 05/11/2011 3:46:02 AM

Wednesday, May 11, 2011 3:46:02 AM

Post# of 257253

I imagine Royalty Pharma's interest is only for the Savella royalty so what happens to the newly licensed compounds?

Good call M. - they've just returned CYP-1020 to BiolineRx.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now